Inhibition of cell cycle progression by penta-acetyl geniposide in rat C6 glioma cells

Toxicology and Applied Pharmacology

Volumn 198, Issue 1, 2004, Pages 11-20

  Chang, Yun Ching ^a   Chou, Fen Pi ^a   Huang, Hui Pei ^a   Hsu, Jeng Dong ^b   Wang, Chau Jong ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

(Ac)5 GP; C6 glioma cell; cdk; cdks; Cell cycle arrest; cyclin dependent kinase; Cyclins; E2F; p21; Penta acetyl geniposide; penta acetyl geniposide; Rb; retinoblastoma; SDS PAGE; sodium dodecyl sulfate polyacrylamide gel electrophoresis; TBS

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; GENIPOSIDE; PENTAACETYLGENIPOSIDE; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISSOCIATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ENZYME INACTIVATION; GLIOMA CELL; GROWTH INHIBITION; IMMUNOPRECIPITATION; INHIBITION KINETICS; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; RAT; RETINOBLASTOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DRUGS, CHINESE HERBAL; GLIOMA; GLUCOSIDES; IRIDOIDS; PHOSPHORYLATION; PLANT EXTRACTS; PYRANS; RATS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2942744667     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.03.004     Document Type: Article

References (50)

1. Adams P.D. Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim. Biophys. Acta. 1471:2001;M123-M133
2. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharmacol. 60:2000;1051-1059
3. Benda P., Lightabody J., Sato G., Levine L., Sweet W. Differentiated rat glial cell strain in tissue culture. Science. 161:1968;370-371
4. Boyd K.E., Farnham P.J. Identification of target genes of oncogenic transcription factors. Proc. Soc. Exp. Biol. Med. 222:1999;9-28
5. Chang Y.C., Tseng T.H., Lee M.J., Hsu J.D., Wang C.J. Induction of apoptosis by penta-acetyl geniposide in rat C6 glioma cells. Chem. Biol. Interact. 141:2002;243-257
6. Connell-Crowley L., Harper J.W., Goodrich D.W. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell. 8:1997;287-301
7. Cordon-Cardo C. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am. J. Pathol. 147:1995;545-560
8. Draetta G., Beach D. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell. 54:1988;17-26
9. Dulic V., Lees E., Reed S.I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science. 257:1992;1958-1969
10. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12:1998;2245-2262
11. Goodger N.M., Gannon J., Hunt T., Morgan P.R. Cell cycle regulatory proteins: an overview with relevance to oral cancer. Oral Oncol. 33:1997;61-73
12. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98:1999;859-869
13. Hiebert S.W., Chellappan S.P., Horowitz J.M., Nevins J.R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:1992;177-185
14. Hirama T., Koeffer H.P. Role of the cyclin-dependent kinase inhibition in the development of cancer. Blood. 86:1995;841-854
15. Hupp T.R., Lane D.P. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J. Biol. Chem. 270:1995;181655-181740
16. Hupp T.R., Sparks A., Lane D.P. Small peptide activates the latent sequence-specific DNA binding function of p53. Cell. 83:1995;237-245
17. Hyde R.K., Griep A.E. Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteons. Invest. Ophthalmol. Vis. Sci. 43:2002;1509-1516
18. Itoi T., Shinohara Y., Takeda K., Nakamura K., Takei K., Sanada J., Horibe T., Saito T., Kasuya K., Ebihara Y. Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis. J. Gastroenterol. 35:2000;142-149
19. Jayaraman L., Prives C. Covalent and noncovalent modifiers of the p53 protein. Cell. Mol. Life Sci. 55:1999;76-87
20. Kaelin W.G. Recent insights into the functions of the retinoblastoma susceptibility gene product. Cancer Invest. 15:1997;243-254
21. Lees J.A., Buchkovich K.J., Marshak D.R., Anderson C.W., Harlow E. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10:1991;4279-4290
22. 1 and dimethylnitrosamine in rats. Carcinogenesis. 7:1986;595-599
23. Lin B.T., Gruenwald S., Morla A.O., Lee W., Wang J.Y. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 10:1991;857-864
24. 1 in rats. Chem. Biol. Interact. 128:2000;115-126
25. MacLachian T.K., Sang N., Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene Expr. 5:1995;127-156
26. Meek D.W. Post-transcriptional modification of p53. Semin. Cancer Biol. 5:1994;203-210
27. Minamoto T., Buschmann T., Habelhah H., Matusevich E., Tahara H., Boerresen-Dale A.L., Harris C., Sidransky D., Ronai Z. Distinct pattern of p53 phosphorylation in human tumors. Oncogene. 20:2001;3341-3347
28. Minshul J., Pines J., Golstein R., Standart N., Mackie S., Colman A., Blow J., Ruderamn J.V., Wu M., Hunt T. The role of cyclin synthesis, modification and destruction in the control of cell division. J. Cell Sci. 12:1989;77-97
29. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134
30. Ortega S., Malumbres M., Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta. 1602:2002;73-87
31. Pfeifer G.P., Denissonko M.F. Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations. Environ. Mol. Mutagen. 31:1998;197-205
32. Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell. 95:1998;5-8
33. Sakaguchi K., Sakamoto H., Lewis M.S., Anderson C.W., Erickson J.W., Appella E., Xie D. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry. 36:1997;10117-10124
34. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677
35. 1-phase progression. Genes Dev. 13:1999;1501-1512
36. Si X., Liu Z. Expression and significance of cell cycle-related proteins cyclin D1, CDK4, p27, E2F-1 and Ets-1 in chondrosarcoma of the jaws. Oral Oncol. 37:2001;431-436
37. Spataro V. Recent advances in the molecular genetics of cancer. Ann. Oncol. 9:1998;23-29
38. Tseng T.H., Chu C.Y., Wang C.J. Inhibition of penta-acetyl geniposide on aflatoxin B1-induced genotoxicity in C3H10T1/2 cells. Cancer Lett. 62:1992;233-242
39. Vidal A., Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene. 247:2000;1-15
40. Vousden K.H. Oncogenes and growth control cells. Biochim. Biophys. Acta. 1423:1998;R29-R33
41. Vousden K.H. Activating of the p53 tumor suppressor protein. Biochim. Biophys. Acta. 1602:2002;47-59
42. Wang C.J., Lin J.K. Inhibitory effects of carotenoids and retinoids on the in vitro growth of rat C6 glioma cells. Proc. Natl. Sci. Counc., Repub. China B. 13:1989;176-183
43. 1 in the rats. Carcinogenesis. 12:1991;459-462
44. Wang C.J., Hsu J.D., Lin J.K. Suppression of aflatoxin B1-induced hepatoxic lesions by crocetin (a natural carotenoids). Carcinogenesis. 1:1991;1807-1810
45. 1 in rats. Cancer Lett. 60:1991;95-102
46. 1-induced DNA repair synthesis in primary cultured rat hepatocytes. Cancer Lett. 65:1992;133-137
47. Wang C.J., Tseng T.H., Lin J.K. Penta-acetyl geniposide: isolation, identification and primary effect on C6 glioma cells in vitro. Anticancer Res. 12:1992;911-916
48. Wang C.J., Chu C.Y., Tseng T.H., Lin J.K. Penta-acetyl geniposide inhibits the growth and development of C6 glioma cells in rats. Cancer Lett. 70:1993;113-118
49. Wang C.J., Lee M.J., Chang M.C., Lin J.K. Inhibition of tumor promotion in benzo (a) pyrene-initiated CD-1 mouse skin by crocetin. Carcinogenesis. 16:1995;187-191
50. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330